文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人眼和复杂性中心性浆液性脉络膜视网膜病变(CSCR)眼中的眼类固醇组。

Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR).

机构信息

Department of Ophthalmology, Cochin Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris Cité, Paris, France.

Centre de Recherche des Cordeliers, INSERM, Physiopathology of Ocular Diseases: Therapeutic Innovations, University Paris Cité, Paris, France.

出版信息

Sci Rep. 2023 Aug 29;13(1):14111. doi: 10.1038/s41598-023-41126-0.


DOI:10.1038/s41598-023-41126-0
PMID:37644063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10465571/
Abstract

The exact link between systemic and ocular endogenous corticoids (steroidome) is unclear and whether the ocular steroidome is altered in CSCR eyes is unknown. The aims of this study were to analyze the human steroidome in the aqueous humor as a function of age, sex and time of the day, to correlate systemic and ocular steroidome and to analyze the ocular steroidome in long lasting complex inactive CSCR. Based on our results, we present two CSCR cases treated by the combination of oral mineralocorticoid antagonist and glucocorticoids drops. In a cross-sectional study, aqueous humor (AH) was collected between 8am and 6 pm from 50 unaffected individuals (25 men and 25 women) and from 14 patients with chronic CSCR, during cataract surgery. In addition, simultaneous serum and AH were collected from 27 individuals undergoing cataract surgery and, simultaneous AH and vitreous were collected from 9 patients undergoing cataract and vitrectomy to estimate corticoids levels in the different compartments. The steroidome was determined using a LC-MS/MS method that quantifies 13 endogenous corticoids from the gluco, mineralocorticoid and androgen pathways. In AH and vitreous, the highest corticoid level is reached by cortisol (F), that represents less than 10% of F serum level. The cortisol levels in the serum did not correlate with ocular cortisol levels. Serum and ocular cortisone (E) levels correlate, although less than 5% of circulating E reaches the eye. The only mineralocorticoids measured in the AH were corticosterone (B) and its inactive form, the 11-desoxycorticosterone (A). There was no influence of circadian rhythm on cortisol ocular levels and there was no correlation between the age or the sex and the level of F, E, A, and B. In eyes with chronic inactive CSCR, the levels of the active glucocorticoid form F was lower than in control eyes and the F/E ratio was reduced by 50% but the B/A ratio was higher indicating imbalance towards active mineralocorticoids. Base on this observation, we propose to combine an antagonist of the mineralocorticoid receptor together with topical glucocorticoids in two CSCR patients, resistant to all other treatments, with favorable outcome. Our results indicate that the ocular psteroidome is highly regulated suggesting a local metabolism of ocular corticoids. In eyes with long-lasting complex inactive CSCR, the steroidome analysis shows lower active glucocorticoids and higher active mineralocorticoids.

摘要

内源性系统性和眼内皮质激素(类固醇组)之间的确切联系尚不清楚,CSCR 眼内的眼内类固醇组是否发生改变也尚不清楚。本研究的目的是分析房水中的人体类固醇组作为年龄、性别和时间的函数,以关联系统性和眼内类固醇组,并分析长期持续的复杂非活动性 CSCR 中的眼内类固醇组。基于我们的结果,我们提出了两种 CSCR 病例,通过联合口服盐皮质激素拮抗剂和糖皮质激素滴注进行治疗。在一项横断面研究中,在白内障手术期间,于上午 8 点至下午 6 点从 50 名无影响个体(25 名男性和 25 名女性)和 14 名慢性 CSCR 患者中收集房水(AH)。此外,同时从 27 名接受白内障手术的个体中收集血清和 AH,并从 9 名接受白内障和玻璃体切除术的患者中同时收集 AH 和玻璃体,以估计不同隔室中的皮质激素水平。使用 LC-MS/MS 方法测定类固醇组,该方法定量测定来自葡糖、盐皮质激素和雄激素途径的 13 种内源性皮质激素。在 AH 和玻璃体中,皮质醇(F)达到最高皮质激素水平,F 仅占血清 F 水平的不到 10%。血清皮质醇水平与眼内皮质醇水平不相关。血清和眼内可的松(E)水平相关,尽管不到 5%的循环 E 到达眼睛。在 AH 中测量的唯一盐皮质激素是皮质酮(B)及其无活性形式 11-去氧皮质酮(A)。昼夜节律对皮质醇眼内水平没有影响,年龄或性别与 F、E、A 和 B 的水平之间没有相关性。在患有慢性非活动性 CSCR 的眼中,活性糖皮质激素形式 F 的水平低于对照眼中,F/E 比值降低了 50%,但 B/A 比值升高,表明向活性盐皮质激素的平衡发生了变化。基于这一观察结果,我们建议在两名对所有其他治疗均有抵抗力的 CSCR 患者中联合使用盐皮质激素受体拮抗剂和局部糖皮质激素治疗,结果良好。我们的结果表明,眼内 psteroidome 受到高度调节,表明眼内皮质激素的局部代谢。在长期持续的复杂非活动性 CSCR 眼中,类固醇组分析显示活性糖皮质激素较低,活性盐皮质激素较高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/96cf070f0ede/41598_2023_41126_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/4fe94330442c/41598_2023_41126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/f0063d61db83/41598_2023_41126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/a6aa096d2af1/41598_2023_41126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/40f884e80616/41598_2023_41126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/157a23368ba0/41598_2023_41126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/c3e138127274/41598_2023_41126_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/a391dd13069b/41598_2023_41126_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/3b256572c6a7/41598_2023_41126_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/a09cc55b7e96/41598_2023_41126_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/96cf070f0ede/41598_2023_41126_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/4fe94330442c/41598_2023_41126_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/f0063d61db83/41598_2023_41126_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/a6aa096d2af1/41598_2023_41126_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/40f884e80616/41598_2023_41126_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/157a23368ba0/41598_2023_41126_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/c3e138127274/41598_2023_41126_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/a391dd13069b/41598_2023_41126_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/3b256572c6a7/41598_2023_41126_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/a09cc55b7e96/41598_2023_41126_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a8c/10465571/96cf070f0ede/41598_2023_41126_Fig10_HTML.jpg

相似文献

[1]
Ocular steroidome in human eyes and in eyes with complex central serous chorioretinopathy (CSCR).

Sci Rep. 2023-8-29

[2]
Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues.

Int J Mol Sci. 2022-1-24

[3]
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.

Prog Retin Eye Res. 2015-5-27

[4]
Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.

J Clin Invest. 2012-6-11

[5]
Effect of eplerenone on choroidal blood flow changes during isometric exercise in patients with chronic central serous chorioretinopathy.

Acta Ophthalmol. 2021-12

[6]
Low incidence of pachydrusen in central serous chorioretinopathy in an Indian cohort.

Indian J Ophthalmol. 2020-1

[7]
Mineralocorticoid Receptor Antagonists in Central Serous Chorioretinopathy: A Meta-Analysis of Randomized Controlled Trials.

Ophthalmol Retina. 2019-2

[8]
[Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy].

Ophthalmologe. 2014-2

[9]
A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.

Am J Ophthalmol. 2016-10

[10]
Combined Topical Anti-inflammatory and Oral Acetazolamide in the Treatment of Central Serous Chorioretinopathy.

Optom Vis Sci. 2019-7

引用本文的文献

[1]
Interventions for central serous chorioretinopathy: a network meta-analysis.

Cochrane Database Syst Rev. 2025-6-16

[2]
Salivary steroids in acute central serous chorioretinopathy.

Int Ophthalmol. 2025-1-29

[3]
Differential Effect of Aldosterone or Mineralocorticoid Receptor Overexpression on Retinal Inflammation.

Invest Ophthalmol Vis Sci. 2024-10-1

[4]
Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy.

Acta Ophthalmol. 2025-5

[5]
PREDNISOLONE EYE DROPS AS A POTENTIAL TREATMENT IN NONNEOVASCULAR PACHYCHOROID-RELATED DISEASES.

Retina. 2024-8-1

本文引用的文献

[1]
First Evidence Indicates the Physiology- and Axial-Myopia-Dependent Profiles of Steroid Hormones in Aqueous Humor.

Metabolites. 2022-12-5

[2]
Topical Dexamethasone as an Adjuvant to Mineralocorticoid Receptor Antagonists for the Treatment of Recalcitrant Central Serous Chorioretinopathy.

Ophthalmic Surg Lasers Imaging Retina. 2022-12

[3]
Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men.

J Clin Med. 2022-3-19

[4]
Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues.

Int J Mol Sci. 2022-1-24

[5]
Mineralocorticoid pathway in retinal health and diseases.

Br J Pharmacol. 2022-7

[6]
Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application.

Int J Clin Pract. 2021-12

[7]
Validation of central serous chorioretinopathy multimodal imaging-based classification system.

Graefes Arch Clin Exp Ophthalmol. 2022-4

[8]
11βHSD2 Efficacy in Preventing Transcriptional Activation of the Mineralocorticoid Receptor by Corticosterone.

J Endocr Soc. 2021-9-3

[9]
Pathogenic Effects of Mineralocorticoid Pathway Activation in Retinal Pigment Epithelium.

Int J Mol Sci. 2021-9-5

[10]
Mineralocorticoid Receptor Pathway and Its Antagonism in a Model of Diabetic Retinopathy.

Diabetes. 2021-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索